These medications are dosed once daily. Baricitinib, or Olumiant, is available in 2 mg or 4 mg per day doses, again, for severe alopecia areata in adults 18 years of age and up.

Leqselvi (deuruxolitinib) 8 mg tablets are approved for adults with severe alopecia areata, a disease that causes the immune system to attack hair follicles, leading to partial or complete hair loss ...

The stigma of having alopecia causes more depression and anxiety than the disease itself, new research has found.

Patients with higher-severity alopecia areata (AA) have a higher prevalence and incidence of comorbid atopic dermatitis (AD), ...

After resolving a patent dispute with Incyte, Sun Pharma has officially launched its JAK inhibitor Leqselvi in the U.S. | Sun ...

The stigma of having alopecia causes more depression and anxiety than the disease itself, new research has found.

India's top drugmaker by revenue Sun Pharma on Monday launched its anti-baldness drug Leqselvi in the U.S., following the ...

Leqselvi ™ (deuruxolitinib) is now available for the treatment of adults with severe alopecia areata.